Research Peptides

ARA-290

ARA-290 (Cibinetide) is a synthetic 11-amino acid peptide derived from the erythropoietin (EPO) molecule, specifically engineered to activate the innate repair receptor (IRR) without erythropoietic effects. It represents a novel approach to tissue protection and repair through the EPO receptor/beta common receptor (βcR) heterodimer pathway. ARA-290 has demonstrated neuroprotective, anti-inflammatory, and tissue-protective properties in multiple clinical trials. We provide research-grade ARA-290 in lyophilized form for institutional research applications.

Technical Specifications

SequencepGlu-Glu-Leu-Arg-Ala-Leu-Gly-Arg-Leu-Leu-Arg
Molecular FormulaC55H100N18O16
Molecular Weight1257.50 g/mol
Purity≥98% (HPLC)
FormLyophilized powder
Storage-20°C, desiccated
CAS1208243-50-8

Application Areas

  • Neuropathic pain research
  • Tissue repair and regeneration studies
  • Small fiber neuropathy investigation
  • Innate repair receptor signaling research
  • Anti-inflammatory pathway studies
  • Sarcoidosis-related neuropathy research

Published Research on ARA-290

Brines M et al. (2008) published in Proceedings of the National Academy of Sciences the discovery that ARA-290 activates the innate repair receptor without erythropoietic activity, opening a new therapeutic paradigm.

Heij L et al. (2012) demonstrated in Molecular Medicine that ARA-290 provides significant relief in sarcoidosis-associated small fiber neuropathy through neuronal protection and regeneration.

Clinical trial results published in Pain (2018) confirmed ARA-290's efficacy in reducing neuropathic pain scores and improving corneal nerve fiber density in diabetic patients.

Frequently Asked Questions About ARA-290

ARA-290 (Cibinetide) is a synthetic 11-amino acid peptide derived from erythropoietin that selectively activates the innate repair receptor (IRR). It promotes tissue protection and repair without stimulating red blood cell production.

We supply ARA-290 at ≥98% (HPLC) purity with full Certificate of Analysis including mass spectrometry and amino acid analysis verification.

ARA-290 selectively activates the IRR (EPO receptor/βcR heterodimer) responsible for tissue repair, without activating the classical EPO receptor homodimer that stimulates erythropoiesis. This provides tissue-protective effects without blood-related side effects.

MOQ for ARA-290 depends on the quantity required. Contact our sales team for specific pricing and availability.

Store ARA-290 at -20°C in lyophilized form. After reconstitution, store at 2-8°C and use within 7 days. ARA-290 is sensitive to oxidation, so minimize exposure to air.

Related Research Peptides

Request Price List